The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Helix Biopharma Corp closed at $1.70.

Over the last five days, shares have gained 3.66% and 18.06% year to date. Shares have outperformed the S&P TSX by 12.53% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.12
Updated December 19 3:52 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJul 31, 201407/31/2014Apr 30, 201404/30/2014Jan 31, 201401/31/2014Oct 31, 201310/31/2013
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense2232
Selling / general / administrative1111
Research & development1121
Depreciation / amortization000--
Interest expense (income), net operating--------
Unusual expense (income)000--
Other operating expenses, total--------
Operating income-2-2-3-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-2-3-2
Income after tax-2-2-3-2
Income tax, total0000
Net income-2-2-3-2
Total adjustments to net income--------
Net income before extra. items-2-2-3-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-2-3-2
Inc. avail. to common incl. extra. items-2-2-3-2
Diluted net income-2-2-3-2
Dilution adjustment--00--
Diluted weighted average shares73727267
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.03-0.04-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.03-0.04-0.03